| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Xu Stella is a Director at Design Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 4 sells.
Estimated insider holdings value: $70.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2022 | DSGN Design Therapeutics, Inc. | Director | Sell | 590,880 | $19.07 | $11,266,197.49 | -3.4% | -15.7% | -64.9% | |
| Mar 30, 2021 | DSGN Design Therapeutics, Inc. | Director, 10% Owner | Buy | 10,000 | $20.00 | $200,000.00 | +0.2% | -22.5% | -45.8% | |
| May 13, 2019 | NXTC Nextcure, Inc. | Director | Buy | 125,000 | $15.00 | $1,875,000.00 | +12.8% | - | - |